Abivax (ABVX)
131.16
0.00 (0.00%)
Upcoming Events
Latest Headlines
Abivax names four commercial leaders ahead of planned NDA filing
July 23, 2026 4:06 PM - StreetInsider
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
July 23, 2026 4:05 PM - Globe NewsWire
Abivax (ABVX) PT Raised to $175; Piper Sandler: 'We remain buyers here'
July 9, 2026 7:11 AM - StreetInsider
Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I
July 6, 2026 9:36 PM - SEC Filing
Form 6-K Abivax S.A. For: Jul 02
July 2, 2026 4:10 PM - SEC Filing
Form 424B5 Abivax S.A.
July 2, 2026 4:07 PM - SEC Filing
Abivax (ABVX) PT Raised to $155 at Truist Securities
July 2, 2026 7:07 AM - StreetInsider
Abivax jumps as fully exercised option lifts share-sale haul to $920 million
July 2, 2026 6:01 AM - StreetInsider
Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease
July 1, 2026 11:53 AM - StreetInsider
Form FWP Abivax S.A. Filed by: Abivax S.A.
July 1, 2026 9:16 AM - SEC Filing
Abivax prices upsized $800M ADS offering at $125 per share
July 1, 2026 9:07 AM - StreetInsider
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
July 1, 2026 9:06 AM - Globe NewsWire
Abivax announces trading resumption of its ordinary shares on Euronext Paris
July 1, 2026 8:56 AM - Globe NewsWire
Abivax prices upsized $800M ADS offering at $125 per share
July 1, 2026 8:37 AM - StreetInsider
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
July 1, 2026 8:37 AM - Globe NewsWire
Abivax (ABVX) Reiterated at Market Outperform by Citizens on Positive ABTECT Data
July 1, 2026 4:39 AM - StreetInsider
Abivax (ABVX) Reiterated at Market Outperform by Citizens on Positive ABTECT Data
July 1, 2026 4:39 AM - StreetInsider
Form FWP Abivax S.A. Filed by: Abivax S.A.
June 30, 2026 5:29 PM - SEC Filing
Form 424B5 Abivax S.A.
June 30, 2026 5:16 PM - SEC Filing
Form POSASR Abivax S.A.
June 30, 2026 4:20 PM - SEC Filing
Jefferies Upgrades Abivax (ABVX) to Buy
June 30, 2026 4:11 PM - StreetInsider
Increasing unusual put volume: SOLS NTR SHW CIA AVAV ABVX LTPH ARKG TTE OLN SOC CHYM VSH
June 30, 2026 10:48 AM - StreetInsider
Guggenheim Reiterates Buy Rating on Abivax (ABVX), 'ABVX remains our Best Idea'
June 30, 2026 6:58 AM - StreetInsider
Abivax (ABVX) PT Raised to $175 at BTIG
June 30, 2026 5:53 AM - StreetInsider
Form 6-K Abivax S.A. For: Jun 29
June 29, 2026 5:22 PM - SEC Filing
Abivax reports Phase 3 maintenance trial results for obefazimod
June 29, 2026 4:06 PM - StreetInsider
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance
June 29, 2026 4:05 PM - Globe NewsWire
Abivax (ABVX) Halted, News Pending
June 29, 2026 4:02 PM - StreetInsider
Wolfe flags a buying opportunity in this biotech stock
June 5, 2026 11:00 AM - StreetInsider
Abivax (ABVX) PT Lowered to $136 at Wolfe Research
June 3, 2026 12:49 PM - StreetInsider
Selloff in this major biotech stock is "overdone," BTIG says
June 2, 2026 11:00 AM - StreetInsider
Abivax (ABVX) PT Lowered to $132 at Morgan Stanley
June 2, 2026 7:50 AM - StreetInsider
Wedbush Upgrades Abivax (ABVX) to Neutral
June 2, 2026 7:08 AM - StreetInsider
Abivax (ABVX) PT Lowered to $135 at Truist Securities
June 2, 2026 7:05 AM - StreetInsider
Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data
June 2, 2026 6:09 AM - StreetInsider
Form 6-K Abivax S.A. For: Jun 01
June 2, 2026 6:08 AM - SEC Filing
Abivax (ABVX) PT Raised to $187 at Citizens
June 2, 2026 4:04 AM - StreetInsider
Jefferies Downgrades Abivax (ABVX) to Hold
June 2, 2026 1:03 AM - StreetInsider
After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
June 1, 2026 4:37 PM - StreetInsider
Abivax reports positive Phase 3 results for ulcerative colitis drug
June 1, 2026 4:05 PM - StreetInsider
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
June 1, 2026 4:05 PM - Globe NewsWire
Abivax (ABVX) Halted, News Pending
June 1, 2026 4:03 PM - StreetInsider
Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation
May 28, 2026 8:35 AM - StreetInsider
Abivax (ABVX) Reiterated at Market Outperform by Citizens on Open-label Results
May 26, 2026 4:40 AM - StreetInsider
Form 6-K Abivax S.A. For: Mar 31
May 22, 2026 4:13 PM - SEC Filing
Abivax reports Q1 2026 results, obefazimod shows sustained remission
May 22, 2026 4:05 PM - StreetInsider
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients
May 22, 2026 4:05 PM - Globe NewsWire
Form 6-K Abivax S.A. For: May 20
May 20, 2026 4:47 PM - SEC Filing
Abivax Announces Results of its May 11, 2026 Annual General Meeting
May 11, 2026 4:05 PM - Globe NewsWire
Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I
May 11, 2026 12:50 PM - SEC Filing
Form 6-K Abivax S.A. For: May 07
May 7, 2026 4:04 PM - SEC Filing
Form 424B7 Abivax S.A.
May 7, 2026 11:33 AM - SEC Filing
Full Article List
